214 related articles for article (PubMed ID: 30119679)
1. Targeting the Tie2-α
Shlamkovich T; Aharon L; Koslawsky D; Einav Y; Papo N
BMC Biol; 2018 Aug; 16(1):92. PubMed ID: 30119679
[TBL] [Abstract][Full Text] [Related]
2. Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy.
Shlamkovich T; Aharon L; Barton WA; Papo N
Oncotarget; 2017 May; 8(20):33571-33585. PubMed ID: 28422724
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic differences in the mechanisms of Tie2 binding to angiopoietins exploited by directed evolution to create an Ang2-selective ligand trap.
Bate N; Lodge J; Brindle NPJ
J Biol Chem; 2021 Aug; 297(2):100888. PubMed ID: 34153320
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
5. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2.
Teichert-Kuliszewska K; Maisonpierre PC; Jones N; Campbell AI; Master Z; Bendeck MP; Alitalo K; Dumont DJ; Yancopoulos GD; Stewart DJ
Cardiovasc Res; 2001 Feb; 49(3):659-70. PubMed ID: 11166279
[TBL] [Abstract][Full Text] [Related]
6. Endothelial destabilization by angiopoietin-2 via integrin β1 activation.
Hakanpaa L; Sipila T; Leppanen VM; Gautam P; Nurmi H; Jacquemet G; Eklund L; Ivaska J; Alitalo K; Saharinen P
Nat Commun; 2015 Jan; 6():5962. PubMed ID: 25635707
[TBL] [Abstract][Full Text] [Related]
7. Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responses.
Pietilä R; Nätynki M; Tammela T; Kangas J; Pulkki KH; Limaye N; Vikkula M; Koh GY; Saharinen P; Alitalo K; Eklund L
J Cell Sci; 2012 May; 125(Pt 9):2212-23. PubMed ID: 22357955
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium.
Yuan HT; Khankin EV; Karumanchi SA; Parikh SM
Mol Cell Biol; 2009 Apr; 29(8):2011-22. PubMed ID: 19223473
[TBL] [Abstract][Full Text] [Related]
9. A collagen IV-derived peptide disrupts α5β1 integrin and potentiates Ang2/Tie2 signaling.
Mirando AC; Shen J; Silva RLE; Chu Z; Sass NC; Lorenc VE; Green JJ; Campochiaro PA; Popel AS; Pandey NB
JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30668550
[TBL] [Abstract][Full Text] [Related]
10. Tie1 controls angiopoietin function in vascular remodeling and inflammation.
Korhonen EA; Lampinen A; Giri H; Anisimov A; Kim M; Allen B; Fang S; D'Amico G; Sipilä TJ; Lohela M; Strandin T; Vaheri A; Ylä-Herttuala S; Koh GY; McDonald DM; Alitalo K; Saharinen P
J Clin Invest; 2016 Sep; 126(9):3495-510. PubMed ID: 27548530
[TBL] [Abstract][Full Text] [Related]
11. A designed angiopoietin-2 variant, pentameric COMP-Ang2, strongly activates Tie2 receptor and stimulates angiogenesis.
Kim HZ; Jung K; Kim HM; Cheng Y; Koh GY
Biochim Biophys Acta; 2009 May; 1793(5):772-80. PubMed ID: 19339208
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface.
Hansen TM; Singh H; Tahir TA; Brindle NP
Cell Signal; 2010 Mar; 22(3):527-32. PubMed ID: 19922791
[TBL] [Abstract][Full Text] [Related]
13. Role of the Ang2-Tie2 Axis in Vascular Damage Driven by High Glucose or Nucleoside Diphosphate Kinase B Deficiency.
Chatterjee A; Eshwaran R; Huang H; Zhao D; Schmidt M; Wieland T; Feng Y
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466219
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietin-2 stimulation of endothelial cells induces alphavbeta3 integrin internalization and degradation.
Thomas M; Felcht M; Kruse K; Kretschmer S; Deppermann C; Biesdorf A; Rohr K; Benest AV; Fiedler U; Augustin HG
J Biol Chem; 2010 Jul; 285(31):23842-9. PubMed ID: 20519501
[TBL] [Abstract][Full Text] [Related]
15. Development of an Orthogonal Tie2 Ligand Resistant to Inhibition by Ang2.
Issa E; Moss AJ; Fischer M; Kang M; Ahmed S; Farah H; Bate N; Giakomidi D; Brindle NP
Mol Pharm; 2018 Sep; 15(9):3962-3968. PubMed ID: 30036484
[TBL] [Abstract][Full Text] [Related]
16. Notoginsenoside R1 activates the Ang2/Tie2 pathway to promote angiogenesis.
Zhong J; Lu W; Zhang J; Huang M; Lyu W; Ye G; Deng L; Chen M; Yao N; Li Y; Liu G; Liang Y; Fu J; Zhang D; Ye W
Phytomedicine; 2020 Nov; 78():153302. PubMed ID: 32823242
[TBL] [Abstract][Full Text] [Related]
17. Directed evolution of an angiopoietin-2 ligand trap by somatic hypermutation and cell surface display.
Brindle NP; Sale JE; Arakawa H; Buerstedde JM; Nuamchit T; Sharma S; Steele KH
J Biol Chem; 2013 Nov; 288(46):33205-12. PubMed ID: 24106271
[TBL] [Abstract][Full Text] [Related]
18. Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer.
Hata K; Udagawa J; Fujiwaki R; Nakayama K; Otani H; Miyazaki K
Oncology; 2002; 62(4):340-8. PubMed ID: 12138242
[TBL] [Abstract][Full Text] [Related]
19. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.
Asahara T; Chen D; Takahashi T; Fujikawa K; Kearney M; Magner M; Yancopoulos GD; Isner JM
Circ Res; 1998 Aug; 83(3):233-40. PubMed ID: 9710115
[TBL] [Abstract][Full Text] [Related]
20. Fetoplacental regional variations in the expression of angiopoietin-1, angiopoietin-2, and Tie2 in normal-term and near-term pregnancies.
De A; Maulik D; Lankachandra K; Mundy DC; Ye SQ; Gerkovich MM
J Matern Fetal Neonatal Med; 2016 Nov; 29(21):3421-8. PubMed ID: 26752164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]